Pangaea Data Joins NVIDIA Inception | BioPharma Dive
BioPharma
Stay updated with breaking news from Pangaea Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A Senior Principal Data Scientist from a leading global pharmaceutical company showcased its success stories of using Pangaea Data’s novel artificial intelligence driven product, PIES (Pangaea’s Intelligence Extractor and Summarization). The presentation took place at the Bio-IT World Conference and Expo and demonstrated that PIES’s inherent Natural Language Generation (NLG) methods provide clinicians and researchers with the ability to generate clinical narratives automatic
Pangaea Data appoints new CFO and three pharmaceutical experts as advisors Pangaea Data appoints new CFO and three pharmaceutical experts as advisors New hires will help drive commercial growth and expansion into the US London, 29 March: Pangaea Data, the UK company that provides a novel AI based software product to its customers from the biopharmaceutical and healthcare industry, has appointed Mr Simon Coulthard as the new CFO, Professor Mark Musen, Dr. Rick Sax and Mr Ozgur Tuncer to its Scientific Advisory Board (SAB). Mr Simon Coulthard is a Fellow of the C...
RACCOON.WORLD RAISES FUNDING FOR PHYSIOTHERAPY TELEMEDICINE EU-based digital physiotherapy startup, Raccoon.World has raised €660K in funding from Fast Track to Innovation (FTI). The money will be spent on further R&D, scientific research and certification of the renewed product, as well as potential partners. The startups' platform, Raccoon.Recovery allows physiotherapy professionals to build a treatment course digitally with patients who have musculoskeletal disorders or are recovering from a stroke. The platform focuses on examination of patient condition to building a gamified exercis...
On the face of it, Britain’s venture capital firms have never been more ready to invest in your start-up. British venture capital funds have £8.4bn ready for investment in fast-growth businesses, according to research. Indeed, British tech start-ups raised more than £4bn between January and June, despite the shutdown of the economy, according to the government. This venture capital cash could provide crucial investment for innovative companies as the country emerges from the Covid-19 crisis. However, the reality is that many venture capital investors are playing it cautious, wanting to i...